4
Changes in Ownership
Jade Biosciences, Inc. Filed Acc 0001415889-23-001966
CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $22.68 ($340,197)
- CHIEF EXECUTIVE OFFICER acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
NOYES TIMOTHY P · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-01 | Exercise or conversion : show line 1 in the form | +15,000 | $2.14 | $32,100 | 15,000 | D |
| 2023-02-01 | Sale : show line 2 in the form | −10,505 | $22.52 | $236,586 | 4,495 | D |
| 2023-02-01 | Sale : show line 3 in the form | −4,495 | $23.05 | $103,611 | 0 | D |
| Open-market sales · 15,000 sh · avg $22.68 · $340,197 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-02-01 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −15,000 | $2.14 | 2031-04-01 | 15,000 | 448,381 | D |
Loading xslF345X03/form4-02032023_060202.xml…